Structured evidence table for Vitamin D Bone Strength Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Vitamin D Bone Strength Randomized Trial | The first group includes supplements supported by a robust theoretical foundation and extensive empirical evidence confirming their efficacy and safety. | 1 | Soltani Mohammad (2026) | Vitamin D Status and Supplementation and the Functional Outcomes of Human Musculoskeletal Tissues: A Stratified Systematic Review |
| Vitamin D Bone Strength Randomized Trial | The second group comprises supplements with a plausible scientific rationale but inconsistent evidence regarding their effectiveness, necessitating further research. | 1 | Soltani Mohammad (2026) | Vitamin D Status and Supplementation and the Functional Outcomes of Human Musculoskeletal Tissues: A Stratified Systematic Review |
| Vitamin D Bone Strength Randomized Trial | Its anti‐inflammatory properties and role in reducing fracture risk, muscle weakness, and tendinopathy are well‐documented [,]. | 1 | Soltani Mohammad (2026) | Vitamin D Status and Supplementation and the Functional Outcomes of Human Musculoskeletal Tissues: A Stratified Systematic Review |
| Vitamin D Bone Strength Randomized Trial | 1 2 3 1 4 5 6 7 8 9 10 11 Dietary supplements, defined as nutrients or compounds ingested to enhance health or performance beyond habitual diets [], are widely used by athletes and the general population [,]. | 1 | Soltani Mohammad (2026) | Vitamin D Status and Supplementation and the Functional Outcomes of Human Musculoskeletal Tissues: A Stratified Systematic Review |
| Vitamin D Bone Strength Randomized Trial | Specifically, 48.0% (12/25) of participants in the alfacalcidol group and 12.0% (3/25) in the control group achieved improvement in muscle mass or function, yielding an absolute difference of 36.0% (95% CI 12.6% – 59.4%; P = 0.005), with a relative risk (RR) of 1.69 (95% CI 1.13–2.53). | 2 | Wang L (2026) | Effect of active vitamin D supplementation on muscle mass and function in peritoneal dialysis patients with sarcopenia: a randomized controlled trial. |
| Vitamin D Bone Strength Randomized Trial | The data regarding the influence of active vitamin D supplementation on muscle mass and function in end-stage renal disease (ESRD) patients have been inconclusive. | 2 | Wang L (2026) | Effect of active vitamin D supplementation on muscle mass and function in peritoneal dialysis patients with sarcopenia: a randomized controlled trial. |
| Vitamin D Bone Strength Randomized Trial | Our study aimed to determine the effectiveness of vitamin D supplementation on the alterations in muscle mass and function in peritoneal dialysis (PD) patients with sarcopenia. | 2 | Wang L (2026) | Effect of active vitamin D supplementation on muscle mass and function in peritoneal dialysis patients with sarcopenia: a randomized controlled trial. |
Source documents